George Eliades

George Eliades

Amministratore Delegato presso
Mythic Therapeutics, Inc.
Health Technology
Commercial Services
Consumer Services

Profilo

George Eliades is currently President & Chief Executive Officer at Mythic Therapeutics, Inc. since 2024 and Director at Pulmonary Fibrosis Foundation.
Formerly, Dr. Eliades was an Independent Director at Oyster Point Pharma, Inc. from 2021 to 2023, Partner at Bain & Co., Inc. from 2007 to 2020, Chief Transformation Officer & SVP-Development at Jazz Pharmaceuticals, Inc., and Chief Transformation Officer at Jazz Pharmaceuticals Plc.
Education includes undergraduate degree from Harvard College, and graduate and doctorate degrees from Harvard University.

Posizioni attive di George Eliades

SocietàPosizioneInizio
Direttore/Membro del Consiglio -
Amministratore Delegato 28/03/2024

Precedenti posizioni note di George Eliades

SocietàPosizioneFine
OYSR POIN Direttore/Membro del Consiglio 03/01/2023
Corporate Officer/Principal 01/12/2020
Corporate Officer/Principal -
JAZZ PHARMACEUTICALS PLC Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di George Eliades

Formazione di George Eliades

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

93

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Health Technology

Consumer Services

Commercial Services

Commercial Services

Health Technology

Consumer Services

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. George Eliades
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA